A detailed history of Simplex Trading, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 463 shares of RCKT stock, worth $6,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
463
Previous 5,825 92.05%
Holding current value
$6,037
Previous $125,000 93.6%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$17.6 - $25.88 $94,371 - $138,768
-5,362 Reduced 92.05%
463 $8,000
Q2 2024

Jul 25, 2024

BUY
$20.66 - $26.72 $120,344 - $155,644
5,825 New
5,825 $125,000
Q3 2023

Nov 01, 2023

BUY
$15.07 - $24.05 $1.54 Million - $2.45 Million
101,928 New
101,928 $2.09 Million
Q1 2023

Apr 27, 2023

BUY
$15.79 - $22.6 $53,449 - $76,501
3,385 New
3,385 $57,000
Q2 2022

Aug 03, 2022

BUY
$7.96 - $16.64 $3,597 - $7,521
452 New
452 $6,000
Q2 2021

Aug 12, 2021

SELL
$39.41 - $47.25 $53,203 - $63,787
-1,350 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$43.34 - $65.91 $44,640 - $67,887
1,030 Added 321.88%
1,350 $59,000
Q4 2020

Feb 02, 2021

SELL
$23.3 - $59.57 $249,333 - $637,458
-10,701 Reduced 97.1%
320 $17,000
Q3 2020

Oct 14, 2020

BUY
$20.5 - $28.59 $41,738 - $58,209
2,036 Added 22.66%
11,021 $251,000
Q2 2020

Jul 13, 2020

SELL
$13.32 - $22.61 $4,115 - $6,986
-309 Reduced 3.32%
8,985 $188,000
Q1 2020

Apr 29, 2020

BUY
$9.71 - $25.11 $90,244 - $233,372
9,294 New
9,294 $129,000
Q3 2019

Oct 15, 2019

SELL
$10.85 - $14.78 $5,500 - $7,493
-507 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$15.0 - $19.81 $7,605 - $10,043
507 New
507 $7,000
Q4 2018

Jan 16, 2019

SELL
$11.21 - $23.53 $50,411 - $105,814
-4,497 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$18.5 - $25.49 $44,381 - $61,150
2,399 Added 114.35%
4,497 $110,000
Q2 2018

Jul 30, 2018

BUY
$14.58 - $23.0 $30,588 - $48,254
2,098 New
2,098 $41,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $987M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.